Discovering active compounds from mixture of natural products by data mining approach

  • Yi Wang
  • Yecheng Jin
  • Chenguang Zhou
  • Haibin Qu
  • Yiyu Cheng
Original Article

Abstract

Traditionally, active compounds were discovered from natural products by repeated isolation and bioassays, which can be highly time consuming. Here, we have developed a data mining approach using the casual discovery algorithm to identify active compounds from mixtures by investigating the correlation between their chemical composition and bioactivity in the mixtures. The efficacy of our algorithm was validated by the cytotoxic effect of Panax ginseng extracts on MCF-7 cells and compared with previous reports. It was demonstrated that our method could successfully pick out active compounds from a mixture in the absence of separation processes. It is expected that the presented algorithm can possibly accelerate the process of discovering new drugs.

Keywords

Quantitative composition–activity relationship Causality Bioassay-guided isolation Drug discovery Traditional chinese medicine 

References

  1. 1.
    Attele AS, Wu JA, Yuan CS (1999) Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58:1685–1693CrossRefGoogle Scholar
  2. 2.
    Borisy AA, Elliott PJ, Hurst NW, Lee MS, Lehar J et al (2003) Systematic discovery of multicomponent therapeutics. Proc Natl Acad Sci USA 100:7977–7982CrossRefGoogle Scholar
  3. 3.
    Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22:1253–1259CrossRefGoogle Scholar
  4. 4.
    Butterweck V, Christoffel V, Nahrstedt A, Petereit F, Spengler B, Winterhoff H (2003) Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Life Sci 73:627–639Google Scholar
  5. 5.
    Cheng Y, Wang Y, Wang X (2006) A causal relationship discovery-based approach to identifying active components of herbal medicine. Comput Biol Chem 30:148–154MATHMathSciNetCrossRefGoogle Scholar
  6. 6.
    Claus BL, Underwood DJ (2002) Discovery informatics: its evolving role in drug discovery. Drug Discov Today 7:957–966CrossRefGoogle Scholar
  7. 7.
    Corbit R, Ebbs S, King ML, Murphy LL (2006) The influence of lead and arsenite on the inhibition of human breast cancer MCF-7 cell proliferation by American ginseng root (Panax quinquefolius L.). Life Sci 78:1336–1340CrossRefGoogle Scholar
  8. 8.
    Harvey A (2000) Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 5:294–300CrossRefGoogle Scholar
  9. 9.
    Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206–220CrossRefGoogle Scholar
  10. 10.
    Misra R (1998) Modern drug development from traditional medicinal plants using radioligand receptor-binding assays. Med Res Rev 18:383–402CrossRefGoogle Scholar
  11. 11.
    O’Connor KA, Roth BL (2005) Screening the receptorome for plant-based psychoactive compounds. Life Sci 78:506–511Google Scholar
  12. 12.
    Orlando M, Meredith LS (2002) Understanding the causal relationship between patient-reported interpersonal and technical quality of care for depression. Med Care 40:696–704CrossRefGoogle Scholar
  13. 13.
    Plavec I, Sirenko O, Privat S, Wang Y, Dajee M et al (2004) Method for analyzing signaling networks in complex cellular systems. Proc Natl Acad Sci USA 101:1223–1228CrossRefGoogle Scholar
  14. 14.
    Spirtes P, Glymour C, Scheines R (1993) Causation, prediction, and search. Springer, New York, 42 ppGoogle Scholar
  15. 15.
    Strege MA (1999) High-performance liquid chromatographic-electrospray ionization mass spectrometric analyses for the integration of natural products with modern high-throughput screening. J Chromatogr B Biomed Sci Appl 725:67–78CrossRefGoogle Scholar
  16. 16.
    Tan G, Gyllenhaal C, Soejarto DD (2006) Biodiversity as a source of anticancer drugs. Curr Drug Targets 7:265–277CrossRefGoogle Scholar
  17. 17.
    Wagner A (1999) Causality in complex systems. Biol Philos 14:83–101CrossRefGoogle Scholar
  18. 18.
    Wang Y, Cheng Y (2003) A strategy for studies on the computational theory and methodology for identifying the composition–activity relationship of Chinese medicine. Chin J Nat Med 1:178–181Google Scholar
  19. 19.
    Wang Y, Pan JY, Xiao XY, Lin RC, Cheng YY (2006) Simultaneous determination of ginsenosides in Panax ginseng with different growth ages using high-performance liquid chromatography–mass spectrometry. Phytochem Anal 17:424–430CrossRefGoogle Scholar
  20. 20.
    Wang Y, Wang X, Cheng Y (2006) A computational approach to botanical drug design by modeling quantitative composition–activity relationship. Chem Biol Drug Des 68:166–172CrossRefGoogle Scholar
  21. 21.
    Xie P, Chen S, Liang YZ, Wang X, Tian R, Upton R (2006) Chromatographic fingerprint analysis—a rational approach for quality assessment of traditional Chinese herbal medicine. J Chromatogr A 1112:171–180CrossRefGoogle Scholar
  22. 22.
    Xu D, Lu Q, Hu X (2006) Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243:274–280CrossRefGoogle Scholar
  23. 23.
    Yu FY, Lin YH, Su CC (2006) A sensitive enzyme-linked immunosorbent assay for detecting carcinogenic aristolochic acid in herbal remedies. J Agric Food Chem 54:2496–2501CrossRefGoogle Scholar
  24. 24.
    Yuan CS, Wang X, Wu JA, Attele AS, Xie JT, Gu M (2001) Effects of Panax quinquefolius L. on brainstem neuronal activities: comparison between Wisconsin-cultivated and Illinois-cultivated roots. Phytomedicine 8:178–183CrossRefGoogle Scholar

Copyright information

© International Federation for Medical and Biological Engineering 2008

Authors and Affiliations

  • Yi Wang
    • 1
  • Yecheng Jin
    • 1
  • Chenguang Zhou
    • 1
  • Haibin Qu
    • 1
  • Yiyu Cheng
    • 1
  1. 1.Pharmaceutical Informatics Institute, College of Pharmaceutical SciencesZhejiang UniversityHangzhouChina

Personalised recommendations